Cell. 2023 Sep 28. pii: S0092-8674(23)00971-6. [Epub ahead of print]186(20): 4386-4403.e29
Na Sun,
Matheus B Victor,
Yongjin P Park,
Xushen Xiong,
Aine Ni Scannail,
Noelle Leary,
Shaniah Prosper,
Soujanya Viswanathan,
Xochitl Luna,
Carles A Boix,
Benjamin T James,
Yosuke Tanigawa,
Kyriaki Galani,
Hansruedi Mathys,
Xueqiao Jiang,
Ayesha P Ng,
David A Bennett,
Li-Huei Tsai,
Manolis Kellis.
Altered microglial states affect neuroinflammation, neurodegeneration, and disease but remain poorly understood. Here, we report 194,000 single-nucleus microglial transcriptomes and epigenomes across 443 human subjects and diverse Alzheimer's disease (AD) pathological phenotypes. We annotate 12 microglial transcriptional states, including AD-dysregulated homeostatic, inflammatory, and lipid-processing states. We identify 1,542 AD-differentially-expressed genes, including both microglia-state-specific and disease-stage-specific alterations. By integrating epigenomic, transcriptomic, and motif information, we infer upstream regulators of microglial cell states, gene-regulatory networks, enhancer-gene links, and transcription-factor-driven microglial state transitions. We demonstrate that ectopic expression of our predicted homeostatic-state activators induces homeostatic features in human iPSC-derived microglia-like cells, while inhibiting activators of inflammation can block inflammatory progression. Lastly, we pinpoint the expression of AD-risk genes in microglial states and differential expression of AD-risk genes and their regulators during AD progression. Overall, we provide insights underlying microglial states, including state-specific and AD-stage-specific microglial alterations at unprecedented resolution.
Keywords: Alzheimer's; cell states; disease-stage response; iPSCs; inflammation; microglia; single-cell; transcription factors